Arab Finance: El Nile Company for Pharmaceuticals and Chemical Industries (Nile Pharma) has posted a 7.35% year-on-year (YoY) increase in net profit before tax during the first 10 months of fiscal year (FY) 2022/2023, according to a filing to the Egyptian Exchange (EGX) on May 21st.
The company recorded net profits before tax of EGP 112.5 million in the 10-month period, compared to EGP 104.8 million in the same period a FY earlier.
Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.